Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumigan versus Glamigan crossover study in glaucoma and ocular hypertension
ACTRN12610000199011Phase 4Not yet recruiting
- Sponsor
- Ophthalmology Department of the State University of Campinas
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bimatoprost in Glaucoma and ocular hypertension (2 arms), sponsored by Ophthalmology Department of the State University of Campinas. Primary endpoint: Diurnal intraocular pressure curve. Planned start May 2010; status: not yet recruiting.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on ACTRN12610000199011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000199011.